Literature DB >> 16628455

Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril.

Corinne Haerdi1, Michael Haessig, Heinz Sager, Gisela Greif, Daniela Staubli, Bruno Gottstein.   

Abstract

Neospora caninum is widely recognized as one of the most important infectious organisms causing abortion and stillbirth in cattle. This parasite causes severe economical losses worldwide. Infection is mostly passed vertically from mother to calf during pregnancy. Under certain circumstances, an infection can lead to abortion, but in most cases it results in a chronically infected calf, which itself will represent the next endogenously infectious generation. So far, no reliable therapeutic or metaphylactic tool has been developed. One possibility to control the problem may consist of treating newborn calves that became vertically infected by a persistently infected mother. This may allow parasite-free offspring. The aim of the present study was to address the questions: (1) can serology be used to assess efficiency of treatment in toltrazuril-medicated animals? and (2) is a strategic prevention measure possible by means of producing N. caninum-free calves from positive cows? Calves from Neospora-seropositive cows and heifers were randomly split into two different medication groups: 36 calves were medicated with toltrazuril and 36 calves obtained a placebo. Medication (20 mg toltrazuril per kg bw) was administered three times, every second day, within the 7 days post natum. Three months after medication, there was no difference in antibody reactivity between the two groups. At later time points (4-6 months), however, significant differences were found, as explained by a strong humoral immunity after chemotherapeutical affection of parasites, while the placebo-treated animals only responded weakly to the persistent infection. In summary, we concluded that (1) serology was not an entirely appropriate tool to answer our initial question and (2) toltrazuril has the potential to eliminate N. caninum in newborn calves. As a consequence, we plan to follow up toltrazuril-medicated calves clinically and serologically over a longer period and investigate if they give birth to Neospora-free calves.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628455     DOI: 10.1007/s00436-006-0199-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  33 in total

Review 1.  A review of Neospora caninum and neosporosis.

Authors:  J P Dubey; D S Lindsay
Journal:  Vet Parasitol       Date:  1996-12-02       Impact factor: 2.738

2.  Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice.

Authors:  B Gottstein; S Eperon; W J Dai; A Cannas; A Hemphill; G Greif
Journal:  Parasitol Res       Date:  2001-01       Impact factor: 2.289

3.  Effect of Neospora caninum infection on milk production in first-lactation dairy cows.

Authors:  M C Thurmond; S K Hietala
Journal:  J Am Vet Med Assoc       Date:  1997-03-01       Impact factor: 1.936

4.  Evaluation of anti-coccidial drugs' inhibition of Neospora caninum development in cell cultures.

Authors:  D S Lindsay; J P Dubey
Journal:  J Parasitol       Date:  1989-12       Impact factor: 1.276

Review 5.  Review of Neospora caninum and neosporosis in animals.

Authors:  J P Dubey; John Dubey
Journal:  Korean J Parasitol       Date:  2003-03       Impact factor: 1.341

6.  Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora caninum infection.

Authors:  S Eperon; K Brönnimann; A Hemphill; B Gottstein
Journal:  Parasite Immunol       Date:  1999-05       Impact factor: 2.280

7.  Immunity to coccidiosis after treatment with toltrazuril.

Authors:  G Greif
Journal:  Parasitol Res       Date:  2000-10       Impact factor: 2.289

8.  Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes.

Authors:  A Harder; A Haberkorn
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  The effects of sym. Triazinones on developmental stages of Eimeria tenella, E. maxima and E. acervulina: a light and electron microscopical study.

Authors:  H Mehlhorn; G Ortmann-Falkenstein; A Haberkorn
Journal:  Z Parasitenkd       Date:  1984

10.  An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum.

Authors:  Sandra Kritzner; Heinz Sager; Jürg Blum; Ralph Krebber; Gisela Greif; Bruno Gottstein
Journal:  Ann Clin Microbiol Antimicrob       Date:  2002-10-18       Impact factor: 3.944

View more
  8 in total

1.  Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.

Authors:  Angela Leepin; Angela Stüdli; Reto Brun; Chad E Stephens; David W Boykin; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

2.  Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice.

Authors:  M Strohbusch; N Müller; A Hemphill; R Krebber; G Greif; B Gottstein
Journal:  Parasitol Res       Date:  2009-02-10       Impact factor: 2.289

Review 3.  Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.

Authors:  M N C Soeiro; K Werbovetz; D W Boykin; W D Wilson; M Z Wang; A Hemphill
Journal:  Parasitology       Date:  2013-04-08       Impact factor: 3.234

Review 4.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

5.  Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice.

Authors:  Michelle Schorer; Karim Debache; Fabienne Barna; Thierry Monney; Joachim Müller; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-02       Impact factor: 4.077

6.  GC/MS analysis of high-performance liquid chromatography fractions from Sophora flavescens and Torilis japonica extracts and their in vitro anti-neosporal effects on Neospora caninum.

Authors:  Hun-Su Seo; Kyoung Hee Kim; Dae-Yong Kim; Bong-Kyun Park; Nam-Shik Shin; Jae-Hoon Kim; Heejeong Youn
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

7.  Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites.

Authors:  Roberto Sánchez-Sánchez; Ignacio Ferre; Michela Re; Patricia Vázquez; Luis Miguel Ferrer; Javier Blanco-Murcia; Javier Regidor-Cerrillo; Manuel Pizarro Díaz; Marta González-Huecas; Enrique Tabanera; Paula García-Lunar; Julio Benavides; Pablo Castaño; Andrew Hemphill; Matthew A Hulverson; Grant R Whitman; Kasey L Rivas; Ryan Choi; Kayode K Ojo; Lynn K Barrett; Wesley C Van Voorhis; Luis Miguel Ortega-Mora
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-02       Impact factor: 4.077

8.  Inhibitory action of phenothiazinium dyes against Neospora caninum.

Authors:  Luiz Miguel Pereira; Caroline Martins Mota; Luciana Baroni; Cássia Mariana Bronzon da Costa; Jade Cabestre Venancio Brochi; Mark Wainwright; Tiago Wilson Patriarca Mineo; Gilberto Úbida Leite Braga; Ana Patrícia Yatsuda
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.